Our partners in the European medical profession share our concerns about the potential impact of Brexit. We have been working closely with them, alongside the EU’s Brexit leads, to mitigate the damage that Brexit will cause to our members and the wider medical profession.
They have written to:
- Dr Ursula von der Leyen, president-elect of the European Commission and Mr David Sassoli, president of the European Parliament
- Michel Barnier, chief negotiator Task Force for the Preparation and Conduct of the Negotiations with the United Kingdom under Article 50 TEU, June 2017
- Antonio Tajani, president of the European Parliament.
EU chief Brexit negotiator Michel Barnier responded in the European Parliament to advise that "doctors working before Brexit can continue to work in their host countries. Their professional qualifications will continue to be recognised, just like in other professions."
BMA council chair Chaand Nagpaul, has also written separately to:
- Professor Dr Frank Ulrich Montgomery - regarding the recognition of professional qualifications, March 2019
- Commissioner Kyriakides - regarding the risks of Brexit on European health systems, October 2019
- Commissioner Gabriel - regarding Brexit's impact on medical research and innovation in Europe, October 2019
- Commissioner Breton - regarding Brexit and the European medical profession, November 2019
- MEP Cristian-Silviu Bușoi, chair of the EP industry, research and energy committee – regarding Brexit and the European medical profession, December 2019.
The BMA and our partners in the European medical profession will continue to lobby key EU Brexit leads to help ensure the best possible outcomes for continued partnership and medical standards across Europe and the EU.
For further information on the BMA’s position on Brexit, please contact the public affairs team: